Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

First bovine respiratory disease vaccine for newborn calves
BOVILIS® INtranasal RSP™ Live vaccine is now licensed for use in calves from birth onwards.

MSD announces only BRD vaccine that can be administered in early life. 

MSD Animal Health has announced the first bovine respiratory disease (BRD) vaccine for newborn calves.

In a press release, the manufacturer said its new BOVILIS® INtranasal RSP™ Live vaccine is now licensed for use in calves from birth onwards. 

It is the only BRD vaccine that can be administered in early life – a significant advantage given that the sooner young calves can be protected from viral BRD and the harm it causes, the better.

An MSD Animal Health spokesperson said: “BOVILISâ INtranasal RSPä Live delivers the fastest on-farm protection of all the available pneumonia vaccines, with an onset of immunity after administration for BRSV of just six days (for calves vaccinated from the day of birth onwards) and five days (for calves vaccinated from the age of one week onwards). 

“Onset of immunity after administration for Pi3V is one week after vaccination. The duration of immunity is 12 weeks for both viruses.”

BRD is caused by bovine respiratory syncytial virus (BRSV) and parainfluenza virus 3 (Pi3).

Early and fast protection against pneumonia is important. Indeed, research published in the Journal of Dairy Science shows that replacement heifers that do not suffer pneumonia while they are calves produce more than 500 kg more milk during their first lactation. 

“BOVILIS® INtranasal RSP™ Live also has significant practical usage benefits in that it can now be used on farm at the same time as other early life interventions associated with newborn calves – for example, colostrum/first milk feeding, navel management, tagging, jacketing and necessary pen movements,” the spokesperson continued.

“Additionally, BOVILIS® INtranasal RSP™ Live can be used up to six hours after mixing with the solvent, which is the longest of all the available intranasal vaccines for these pathogens. It is supplied as a farm-friendly, easy-to administer nasal suspension product that doesn’t need a specific applicator – although for maximum flexibility an easy-clean injector and nozzle kit is available for vaccinating multiple animals.”

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.